Reduction of conditioned pain modulation in humans by naltrexone: An exploratory study of the effects of pain catastrophizing

Journal of Behavioral Medicine

Volumn 36, Issue 3, 2013, Pages 315-327

  King, Christopher D ^a   Goodin, Burel ^a   Kindler, Lindsay L ^a   Caudle, Robert M ^a   Edwards, Robert R ^b   Gravenstein, Nikolaus ^c   Riley III, Joseph L ^a   Fillingim, Roger B ^a,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Catastrophizing; Conditioned pain modulation; Diffuse noxious inhibitory control; Endogenous opioids; Heat pain; Naltrexone

Indexed keywords

NALTREXONE; NARCOTIC ANTAGONIST; OPIATE PEPTIDE;

ADULT; ARTICLE; CATASTROPHIZING; CONDITIONED REFLEX; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIFFUSE NOXIOUS INHIBITORY CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INDIVIDUALITY; MALE; PAIN; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT; DRUG EFFECTS; PSYCHOLOGY;

ADULT; CATASTROPHIZATION; CONDITIONING, CLASSICAL; CROSS-OVER STUDIES; DIFFUSE NOXIOUS INHIBITORY CONTROL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDIVIDUALITY; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; PAIN; PAIN THRESHOLD; YOUNG ADULT;

EID: 84875344583     PISSN: 01607715     EISSN: 15733521     Source Type: Journal    
DOI: 10.1007/s10865-012-9424-2     Document Type: Article

References (87)

1. al'Absi, M., Wittmers, L. E., Ellestad, D., Nordehn, G., Kim, S. W., Kirschbaum, C., et al. (2004). Sex differences in pain and hypothalamic- pituitary-adrenocortical responses to opioid blockade. Psychosomatic Medicine, 66, 198-206.
2. Bandura, A., O'Leary, A., Taylor, C. B., Gauthier, J., & Gossard, D. (1987). Perceived self-efficacy and pain control: Opioid and nonopioid mechanisms. Journal of Personality and Social Psychology, 53, 563-571.
3. Bartley, E. J., & Rhudy, J. L. (2008). The influence of pain catastrophizing on experimentally induced emotion and emotional modulation of nociception. J Pain, 9, 388-396.
4. Basbaum, A. I., & Fields, H. L. (1984). Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annual Review of Neuroscience, 7, 309-338.
5. Bouhassira, D., Bing, Z., & Lebars, D. (1993). Studies of brain structures involved in diffuse noxious inhibitory controls in the rat - the rostral ventromedial medulla. Journal of Physiology-London, 463, 667-687.
6. Bruehl, S., Burns, J. W., Chung, O. Y., Magid, E., Chont, M., Gilliam, W., et al. (2010). Hypoalgesia associated with elevated resting blood pressure: Evidence for endogenous opioid involvement. Journal of Behavioral Medicine, 33, 168-176.
7. Bruehl, S., Chung, O. Y., Ward, P., Johnson, B., & McCubbin, J. A. (2002). The relationship between resting blood pressure and acute pain sensitivity in healthy normotensives and chronic back pain sufferers: The effects of opioid blockade. Pain, 100, 191-201.
8. Burns, J. W., Bruehl, S., Chung, O. Y., Magid, E., Chont, M., Goodlad, J. K., et al. (2009). Endogenous opioids may buffer effects of anger arousal on sensitivity to subsequent pain. Pain, 146, 276-282.
9. Campbell, C. M., & Edwards, R. R. (2009). Mind-body interactions in pain: The neurophysiology of anxious and catastrophic pain-related thoughts. Translational Research, 153, 97-101.
10. Campbell, C. M., Kronfli, T., Buenaver, L. F., Smith, M. T., Berna, C., Haythornthwaite, J. A., et al. (2010a). Situational versus dispositional measurement of catastrophizing: Associations with pain responses in multiple samples. The Journal of Pain, 11, 443 e442-453 e442.
11. Campbell, C. M., Witmer, K., Simango, M., Carteret, A., Loggia, M. L., Campbell, J. N., et al. (2010b). Catastrophizing delays the analgesic effect of distraction. Pain, 149, 202-207.
12. Cano, A., Leonard, M. T., & Franz, A. (2005). The significant other version of the Pain Catastrophizing Scale (PCS-S): Preliminary validation. Pain, 119, 26-37.
13. Casale, G., Pecorini, M., Cuzzoni, G., & de Nicola, P. (1985). Beta-endorphin and cold pressor test in the aged. Gerontology, 31, 101-105.
14. Chitour, D., Dickenson, A. H., & Lebars, D. (1982). Pharmacological evidence for the involvement of serotonergic mechanisms in diffuse noxious inhibitory controls (DNIC). Brain Research, 236, 329-337.
15. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: L. Erlbaum Associates.
16. Crabtree, B. L. (1984). Review of naltrexone, a long-acting opiate antagonist. Clin Pharm, 3, 273-280.
17. Edwards, R. R. (2005). Individual differences in endogenous pain modulation as a risk factor for chronic pain. Neurology, 65, 437-443.
18. Edwards, R. R., Campbell, C. M., & Fillingim, R. B. (2005). Catastrophizing and experimental pain sensitivity: Only in vivo reports of catastrophic cognitions correlate with pain responses. The Journal of Pain, 6, 338-339.
19. Edwards, R. R., Fillingim, R. B., & Ness, T. J. (2003). Age-related differences in endogenous pain modulation: A comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain, 101, 155-165.
20. Edwards, R. R., Kronfli, T., Haythornthwaite, J. A., Smith, M. T., McGuire, L., & Page, G. G. (2008). Association of catastrophizing with interleukin-6 responses to acute pain. Pain, 140, 135-144.
21. Edwards, R. R., Ness, T. J., & Fillingim, R. B. (2004). Endogenous opioids, blood pressure, and diffuse noxious inhibitory controls: A preliminary study. Perceptual and Motor Skills, 99, 679-687.
22. Edwards, R. R., Smith, M. T., Stonerock, G., & Haythornthwaite, J. A. (2006). Pain-related catastrophizing in healthy women is associated with greater temporal summation of and reduced habituation to thermal pain. Clinical Journal of Pain, 22, 730-737.
23. France, C. R., al'Absi, M., Ring, C., France, J. L., Harju, A., & Wittmers, L. E. (2007). Nociceptive flexion reflex and pain rating responses during endogenous opiate blockade with naltrexone in healthy young adults. Biological Psychology, 75, 95-100.
24. Frid, M., Singer, G., & Rana, C. (1979). Interactions between personal expectations and naloxone: Effects on tolerance to ischemic pain. Psychopharmacology (Berlin), 65, 225-231.
25. Gjerstad, J., Tjolsen, A., Svendsen, F., & Hole, K. (2000). Inhibition of spinal nociceptive responses after intramuscular injection of capsaicin involves activation of noradrenergic and opioid systems. Brain Research, 859, 132-136.
26. Goffaux, P., de Souza, J. B., Potvin, S., & Marchand, S. (2009). Pain relief through expectation supersedes descending inhibitory deficits in fibromyalgia patients. Pain, 145, 18-23.
27. Goffaux, P., Redmond, W. J., Rainville, P., & Marchand, S. (2007). Descending analgesia - when the spine echoes what the brain expects. Pain, 130, 137-143.
28. Gonzalez, J. P., & Brogden, R. N. (1988). Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs, 35, 192-213.
29. Goodin, B. R., McGuire, L. M., Stapleton, L. M., Quinn, N. B., Fabian, L. A., Haythornthwaite, J. A., et al. (2009). Pain catastrophizing mediates the relationship between self-reported strenuous exercise involvement and pain ratings: Moderating role of anxiety sensitivity. Psychosomatic Medicine, 71, 1018-1025.
30. Gracely, R. H., Geisser, M. E., Giesecke, T., Grant, M. A., Petzke, F., Williams, D. A., et al. (2004). Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain, 127, 835-843.
31. Granot, M., Granovsky, Y., Sprecher, E., Nir, R. R., & Yarnitsky, D. (2006). Contact heat-evoked temporal summation: Tonic versus repetitive-phasic stimulation. Pain, 122, 295-305.
32. Granot, M., Weissman-Fogel, I., Crispel, Y., Pud, D., Granovsky, Y., Sprecher, E., et al. (2008). Determinants of endogenous analgesia magnitude in a diffuse noxious inhibitory control (DNIC) paradigm: Do conditioning stimulus painfulness, gender and personality variables matter? Pain, 136, 142-149.
33. Heymen, S., Maixner, W., Whitehead, W. E., Klatzkin, R. R., Mechlin, B., & Light, K. C. (2010). Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls. Clinical Journal of Pain, 26, 104-109.
34. Jiang, J. B., Hanson, R. N., Portoghese, P. S., & Takemori, A. E. (1977). Stereochemical studies on medicinal agents. 23. Synthesis and biological evaluation of 6-amino derivatives of naloxone and naltrexone. Journal of Medicinal Chemistry, 20, 1100-1102.
35. Kelly, S. J., & Franklin, K. B. (1987). Role of peripheral and central opioid activity in analgesia induced by restraint stress. Life Sciences, 41, 789-794.
36. King, C. D., Devine, D. P., Vierck, C. J., Mauderli, A., & Yezierski, R. P. (2007). Opioid modulation of reflex versus operant responses following stress in the rat. Neuroscience, 147, 174-182.
37. King, C. D., Wong, F., Currie, T., Mauderli, A. P., Fillingim, R. B., & Riley, J. L., I. I. I. (2009). Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain, 143, 172-178.
38. Kotlyar, M., al'Absi, M., Brauer, L. H., Grant, J. E., Fong, E., & Kim, S. W. (2008). Naltrexone effect on physiological and subjective response to a cold pressor task. Biological Psychology, 77, 233-236.
39. Kraus, E., Besson, J. M., & Lebars, D. (1982). Behavioral model for diffuse noxious inhibitory controls (DNIC) - potentation by 5-hydroxytryptophan. Brain Research, 231, 461-465.
40. Kraus, E., Le Bars, D., & Besson, J. M. (1981). Behavioral confirmation of "diffuse noxious inhibitory controls" (DNIC) and evidence for a role of endogenous opiates. Brain Research, 206, 495-499.
41. Lautenbacher, S., Prager, M., & Rollman, G. B. (2007). Pain additivity, diffuse noxious inhibitory controls, and attention: A functional measurement analysis. Somatosensory and Motor Research, 24, 189-201.
42. Le Bars, D., Chitour, D., Kraus, E., Dickenson, A. H., & Besson, J. M. (1981). Effect of naloxone upon diffuse noxious inhibitory controls (DNIC) in the rat. Brain Research, 204, 387-402.
43. Lee, M. C., Wagner, H. N., Jr, Tanada, S., Frost, J. J., Bice, A. N., & Dannals, R. F. (1988). Duration of occupancy of opiate receptors by naltrexone. Journal of Nuclear Medicine, 29, 1207-1211.
44. Maixner, W., Fillingim, R., Booker, D., & Sigurdsson, A. (1995). Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain, 63, 341-351.
45. Meyer, M. C., Straughn, A. B., Lo, M. W., Schary, W. L., & Whitney, C. C. (1984). Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration. Journal of Clinical Psychiatry, 45, 15-19.
46. Millan, M. J. (2002). Descending control of pain. Progress in Neurobiology, 66, 355-474.
47. Moont, R., Pud, D., Sprecher, E., Sharvit, G., & Yarnitsky, D. (2010). 'Pain inhibits pain' mechanisms: Is pain modulation simply due to distraction? Pain, 150, 113-120.
48. Naert, A. L., Kehlet, H., & Kupers, R. (2008). Characterization of a novel model of tonic heat pain stimulation in healthy volunteers. Pain, 138, 163-171.
49. Pert, C. B., Pasternak, G., & Snyder, S. H. (1973). Opiate agonists and antagonists discriminated by receptor binding in brain. Science, 182, 1359-1361.
50. Pertovaara, A., Kemppainen, P., Johansson, G., & Karonen, S. L. (1982). Ischemic pain non-segmentally produces a predominant reduction of pain and thermal sensitivity in man - a selective role for endogenous opioids. Brain Research, 251, 83-92.
51. Peters, M. L., Schmidt, A. J., Van den Hout, M. A., Koopmans, R., & Sluijter, M. E. (1992). Chronic back pain, acute postoperative pain and the activation of diffuse noxious inhibitory controls (DNIC). Pain, 50, 177-187.
52. Picavet, H. S., Vlaeyen, J. W., & Schouten, J. S. (2002). Pain catastrophizing and kinesiophobia: Predictors of chronic low back pain. American Journal of Epidemiology, 156, 1028-1034.
53. Piche, M., Arsenault, M., & Rainville, P. (2009). Cerebral and cerebrospinal processes underlying counterirritation analgesia. Journal of Neuroscience, 29, 14236-14246.
54. Pielsticker, A., Haag, G., Zaudig, M., & Lautenbacher, S. (2005). Impairment of pain inhibition in chronic tension-type headache. Pain, 118, 215-223.
55. Popescu, A., LeResche, L., Truelove, E. L., & Drangsholt, M. T. (2010). Gender differences in pain modulation by diffuse noxious inhibitory controls: A systematic review. Pain, 150, 309-318.
56. Porter, S. J., Somogyi, A. A., & White, J. M. (2002). In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone. Addiction Biology, 7, 219-225.
57. Price, D. D., & McHaffie, J. G. (1988). Effects of heterotopic conditioning stimuli on first and second pain: A psychophysical evaluation in humans. Pain, 34, 245-252.
58. Pruessner, J. C., Kirschbaum, C., Meinlschmid, G., & Hellhammer, D. H. (2003). Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology, 28, 916-931.
59. Pud, D., Granovsky, Y., & Yarnitsky, D. (2009). The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans. Pain, 144, 16-19.
60. Quiton, R. L., & Greenspan, J. D. (2008). Across- and within-session variability of ratings of painful contact heat stimuli. Pain, 137, 245-256.
61. Riley, J. L., Hastie, B. A., Glover, T. L., Fillingim, R. B., Staud, R., & Campbell, C. M. (2010a). Cognitive-affective and somatic side effects of morphine and pentazocine: Side-effect profiles in healthy adults. Pain Medicine, 11, 195-206.
62. Riley, J., King, C., Wong, F., Fillingim, R. B., & Mauderli, A. P. (2010b). Lack of endogenous modulation and reduced decay of prolonged heat pain in older adults. Pain, 150, 153-160.
63. Ring, C., France, C. R., al'Absi, M., Beesley, L., Edwards, L., McIntyre, D., et al. (2007). Effects of opioid blockade with naltrexone and distraction on cold and ischemic pain in hypertension. Journal of Behavioral Medicine, 30, 59-68.
64. Rosa, C., Ghione, S., Mezzasalma, L., Pellegrini, M., Basile Fasolo, C., Giaconi, S., et al. (1988). Relationship between pain sensitivity, cardiovascular reactivity to cold pressor test and indexes of activity of the adrenergic and opioid system. Clin Exp Hypertens A, 10, 383-390.
65. Song, G. H., Venkatraman, V., Ho, K. Y., Chee, M. W., Yeoh, K. G., & Wilder-Smith, C. H. (2006). Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain, 126, 79-90.
66. Sprenger, C., Bingel, U., & Buchel, C. (2011). Treating pain with pain: Supraspinal mechanisms of endogenous analgesia elicited by heterotopic noxious conditioning stimulation. Pain, 152, 428-439.
67. Staud, R., Robinson, M. E., Vierck, C. J., Jr., & Price, D. D. (2003). Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain, 101, 167-174.
68. Sullivan, M. J., Bishop, S. R., & Pivik, J. (1995). The pain catastrophizing scale: Development and validation. Psychological Assessment, 7, 524-532.
69. Suzuki, K., Maekawa, K., Minakuchi, H., Yatani, H., Clark, G. T., Matsuka, Y., et al. (2007). Responses of the hypothalamic-pituitary-adrenal axis and pain threshold changes in the orofacial region upon cold pressor stimulation in normal volunteers. Archives of Oral Biology, 52, 797-802.
70. Takemori, A. E., & Portoghese, P. S. (1984). Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists. European Journal of Pharmacology, 104, 101-104.
71. Tepperman, F. S., Hirst, M., & Smith, P. (1983). Brain and serum levels of naloxone following peripheral administration. Life Sciences, 33, 1091-1096.
72. Tousignant-Laflamme, Y., Page, S., Goffaux, P., & Marchand, S. (2008). An experimental model to measure excitatory and inhibitory pain mechanisms in humans. Brain Research, 1230, 73-79.
73. Tricklebank, M. D., Hutson, P. H., & Curzon, G. (1984). Analgesia induced by brief or more prolonged stress differs in its dependency on naloxone, 5-hydroxytryptamine and previous testing of analgesia. Neuropharmacology, 23, 417-421.
74. van Wijk, G., & Veldhuijzen, D. S. (2010). Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. J Pain, 11, 408-419.
75. Verebey, K. (1981). The clinical pharmacology of naltrexone: Pharmacology and pharmacodynamics. NIDA Research Monograph, 28, 147-158.
76. Villanueva, L. (2009). Diffuse noxious inhibitory control (DNIC) as a tool for exploring dysfunction of endogenous pain modulatory systems. Pain, 143, 161-162.
77. Walsh, S. L., Sullivan, J. T., Preston, K. L., Garner, J. E., & Bigelow, G. E. (1996). Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. Journal of Pharmacology and Experimental Therapeutics, 279, 524-538.
78. Washington, L. L., Gibson, S. J., & Helme, R. D. (2000). Age-related differences in the endogenous analgesic response to repeated cold water immersion in human volunteers. Pain, 89, 89-96.
79. Weissman-Fogel, I., Sprecher, E., & Pud, D. (2008). Effects of catastrophizing on pain perception and pain modulation. Experimental Brain Research, 186, 79-85.
80. Wen, Y.-R., Wang, C.-C., Yeh, G.-C., Hsu, S.-F., Huang, Y.-J., Li, Y.-L., et al. (2010). DNIC-mediated analgesia produced by a supramaximal electrical or a high-dose formalin conditioning stimulus: Roles of opioid and alpha2-adrenergic receptors. Journal of Biomedical Science, 17, 19.
81. Wilder-Smith, C. H., Schindler, D., Lovblad, K., Redmond, S. M., & Nirkko, A. (2004). Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut, 53, 1595-1601.
82. Wilder-Smith, C. H., Song, G., Yeoh, K. G., & Ho, K. Y. (2009). Activating endogenous visceral pain modulation: A comparison of heterotopic stimulation methods in healthy controls. European Journal of Pain, 13, 836-842.
83. Willer, J. C., Le Bars, D., & De Broucker, T. (1990). Diffuse noxious inhibitory controls in man: Involvement of an opioidergic link. European Journal of Pharmacology, 182, 347-355.
84. Willer, J. C., Roby, A., & Le Bars, D. (1984). Psychophysical and electrophysiological approaches to the pain-relieving effects of heterotopic nociceptive stimuli. Brain, 107, 1095-1112.
85. Wong, F., Vierck, C. J., Riley, J. L., King, C., & Mauderli, A. P. (2010). A new thermal stimulation method for human psychophysical studies: Pain intensity clamping. Journal of Neuroscience Methods, 188, 83-88.
86. Yarnitsky, D., Arendt-Nielsen, L., Bouhassira, D., Edwards, R. R., Fillingim, R. B., Granot, M., et al. (2010). Recommendations on terminology and practice of psychophysical DNIC testing. European Journal of Pain, 14, 339.
87. Zimmerman, D. M., & Leander, J. D. (1990). Opioid antagonists: Structure activity relationships. NIDA Research Monograph, 96, 50-60.